Concepts (228)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aging | 26 | 2023 | 1560 | 2.630 |
Why?
|
| Cognition | 22 | 2023 | 1352 | 1.720 |
Why?
|
| Alzheimer Disease | 26 | 2023 | 2123 | 1.680 |
Why?
|
| Brain | 24 | 2023 | 1690 | 1.670 |
Why?
|
| White Matter | 8 | 2022 | 142 | 1.170 |
Why?
|
| Memory Disorders | 9 | 2018 | 168 | 1.140 |
Why?
|
| Aged | 55 | 2023 | 9222 | 1.040 |
Why?
|
| Mental Recall | 8 | 2008 | 70 | 1.010 |
Why?
|
| Magnetic Resonance Imaging | 23 | 2023 | 1181 | 0.990 |
Why?
|
| Attention | 5 | 2009 | 139 | 0.960 |
Why?
|
| Cognitive Dysfunction | 7 | 2023 | 1035 | 0.930 |
Why?
|
| Diffusion Tensor Imaging | 4 | 2023 | 66 | 0.920 |
Why?
|
| Aged, 80 and over | 38 | 2021 | 4846 | 0.910 |
Why?
|
| Gray Matter | 4 | 2016 | 55 | 0.790 |
Why?
|
| Neuropsychological Tests | 20 | 2022 | 1258 | 0.740 |
Why?
|
| Humans | 68 | 2023 | 28054 | 0.690 |
Why?
|
| Male | 51 | 2023 | 15143 | 0.670 |
Why?
|
| Female | 49 | 2023 | 15534 | 0.650 |
Why?
|
| Visual Perception | 4 | 2007 | 35 | 0.650 |
Why?
|
| Prefrontal Cortex | 5 | 2018 | 148 | 0.640 |
Why?
|
| Brain Mapping | 9 | 2021 | 168 | 0.610 |
Why?
|
| Dementia | 6 | 2022 | 569 | 0.610 |
Why?
|
| Acculturation | 3 | 2023 | 37 | 0.590 |
Why?
|
| Memory | 9 | 2021 | 309 | 0.570 |
Why?
|
| Motor Activity | 3 | 2015 | 329 | 0.520 |
Why?
|
| Semantics | 3 | 2008 | 19 | 0.520 |
Why?
|
| Genome-Wide Association Study | 7 | 2019 | 287 | 0.510 |
Why?
|
| Cues | 7 | 2007 | 50 | 0.510 |
Why?
|
| Inflammation | 4 | 2022 | 287 | 0.490 |
Why?
|
| Cerebral Cortex | 2 | 2021 | 167 | 0.490 |
Why?
|
| Neuroimaging | 4 | 2022 | 133 | 0.490 |
Why?
|
| Motor Skills | 1 | 2015 | 54 | 0.470 |
Why?
|
| Cognition Disorders | 11 | 2018 | 1019 | 0.440 |
Why?
|
| Hippocampus | 6 | 2022 | 281 | 0.420 |
Why?
|
| Image Processing, Computer-Assisted | 7 | 2023 | 189 | 0.410 |
Why?
|
| Geriatric Assessment | 3 | 2009 | 214 | 0.410 |
Why?
|
| Neural Pathways | 6 | 2014 | 72 | 0.380 |
Why?
|
| Longitudinal Studies | 10 | 2023 | 1366 | 0.340 |
Why?
|
| Vocabulary | 3 | 1999 | 13 | 0.340 |
Why?
|
| Anisotropy | 5 | 2023 | 53 | 0.330 |
Why?
|
| Pattern Recognition, Visual | 8 | 2005 | 27 | 0.330 |
Why?
|
| Functional Laterality | 2 | 2008 | 69 | 0.320 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 117 | 0.320 |
Why?
|
| Disease Progression | 3 | 2009 | 718 | 0.310 |
Why?
|
| Memory, Short-Term | 3 | 2021 | 104 | 0.300 |
Why?
|
| Reaction Time | 4 | 2021 | 115 | 0.300 |
Why?
|
| Activities of Daily Living | 3 | 2009 | 540 | 0.290 |
Why?
|
| Verbal Learning | 3 | 2004 | 37 | 0.280 |
Why?
|
| Loneliness | 2 | 2018 | 57 | 0.270 |
Why?
|
| Antibodies, Antiphospholipid | 2 | 2019 | 25 | 0.260 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2005 | 10 | 0.250 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2016 | 281 | 0.240 |
Why?
|
| Cohort Studies | 11 | 2019 | 1882 | 0.240 |
Why?
|
| Decision Making | 3 | 2016 | 229 | 0.230 |
Why?
|
| Parkinsonian Disorders | 1 | 2007 | 227 | 0.220 |
Why?
|
| Health Status | 2 | 2009 | 227 | 0.210 |
Why?
|
| Middle Aged | 16 | 2019 | 9186 | 0.210 |
Why?
|
| Arteriolosclerosis | 1 | 2023 | 78 | 0.210 |
Why?
|
| Entorhinal Cortex | 2 | 2017 | 36 | 0.200 |
Why?
|
| Adult | 13 | 2022 | 8021 | 0.200 |
Why?
|
| Genetic Variation | 2 | 2019 | 98 | 0.190 |
Why?
|
| Health Literacy | 1 | 2023 | 109 | 0.190 |
Why?
|
| Linear Models | 4 | 2018 | 253 | 0.190 |
Why?
|
| Comprehension | 2 | 2016 | 31 | 0.190 |
Why?
|
| Psychology | 1 | 2021 | 24 | 0.180 |
Why?
|
| Neuropathology | 2 | 2019 | 84 | 0.180 |
Why?
|
| Parkinson Disease | 2 | 2016 | 846 | 0.180 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2021 | 70 | 0.180 |
Why?
|
| Social Environment | 1 | 2021 | 85 | 0.180 |
Why?
|
| Drosophila melanogaster | 1 | 2019 | 17 | 0.170 |
Why?
|
| Hypertension | 1 | 2022 | 225 | 0.170 |
Why?
|
| Age Factors | 5 | 2016 | 788 | 0.170 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2019 | 19 | 0.160 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 349 | 0.160 |
Why?
|
| Motor Disorders | 1 | 2019 | 24 | 0.160 |
Why?
|
| Lateral Ventricles | 1 | 2018 | 6 | 0.160 |
Why?
|
| Mental Status Schedule | 4 | 2018 | 97 | 0.160 |
Why?
|
| Genome, Human | 1 | 2018 | 45 | 0.150 |
Why?
|
| Statistics as Topic | 3 | 2011 | 116 | 0.150 |
Why?
|
| Actigraphy | 2 | 2016 | 97 | 0.150 |
Why?
|
| Delay Discounting | 1 | 2018 | 25 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 380 | 0.150 |
Why?
|
| Perceptual Disorders | 1 | 1997 | 6 | 0.150 |
Why?
|
| Organ Size | 4 | 2019 | 105 | 0.140 |
Why?
|
| Reading | 4 | 2004 | 42 | 0.140 |
Why?
|
| Risk Factors | 3 | 2023 | 2371 | 0.140 |
Why?
|
| Gene Expression | 1 | 2018 | 206 | 0.140 |
Why?
|
| Amyloid | 1 | 2017 | 57 | 0.140 |
Why?
|
| Nucleus Accumbens | 1 | 2016 | 14 | 0.140 |
Why?
|
| Perception | 1 | 1997 | 77 | 0.130 |
Why?
|
| Disability Evaluation | 2 | 2009 | 290 | 0.130 |
Why?
|
| Intelligence | 1 | 2016 | 21 | 0.130 |
Why?
|
| Neurofibrillary Tangles | 1 | 2017 | 194 | 0.130 |
Why?
|
| Economics | 1 | 2016 | 18 | 0.130 |
Why?
|
| Cerebrovascular Circulation | 1 | 2016 | 35 | 0.130 |
Why?
|
| Neocortex | 1 | 2016 | 32 | 0.130 |
Why?
|
| Cerebral Infarction | 2 | 2016 | 150 | 0.120 |
Why?
|
| Cognitive Aging | 1 | 2016 | 79 | 0.120 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 44 | 0.120 |
Why?
|
| Sleep Deprivation | 1 | 2016 | 76 | 0.120 |
Why?
|
| Microglia | 1 | 2016 | 144 | 0.120 |
Why?
|
| Gyrus Cinguli | 1 | 2014 | 17 | 0.120 |
Why?
|
| Thiazolidinediones | 1 | 2014 | 9 | 0.110 |
Why?
|
| Financial Management | 1 | 2014 | 24 | 0.110 |
Why?
|
| Central Nervous System Agents | 1 | 2014 | 8 | 0.110 |
Why?
|
| Logistic Models | 1 | 2015 | 395 | 0.110 |
Why?
|
| Pyridines | 1 | 2014 | 37 | 0.110 |
Why?
|
| Cerebellum | 1 | 2013 | 43 | 0.110 |
Why?
|
| Reward | 1 | 2013 | 27 | 0.110 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 42 | 0.110 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2013 | 28 | 0.110 |
Why?
|
| Choice Behavior | 1 | 2013 | 47 | 0.110 |
Why?
|
| Cross-Sectional Studies | 2 | 2007 | 928 | 0.110 |
Why?
|
| Epidemiologic Research Design | 1 | 2012 | 16 | 0.100 |
Why?
|
| Verbal Behavior | 2 | 2005 | 18 | 0.100 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 1809 | 0.100 |
Why?
|
| Musculoskeletal Pain | 1 | 2012 | 21 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2012 | 4 | 0.100 |
Why?
|
| Time Factors | 5 | 2013 | 1485 | 0.100 |
Why?
|
| Autopsy | 3 | 2018 | 346 | 0.100 |
Why?
|
| Movement Disorders | 1 | 2012 | 91 | 0.100 |
Why?
|
| Risk-Taking | 1 | 2011 | 36 | 0.090 |
Why?
|
| Chronic Pain | 1 | 2012 | 111 | 0.090 |
Why?
|
| Genetic Loci | 3 | 2017 | 54 | 0.090 |
Why?
|
| Muscle Strength | 2 | 2009 | 138 | 0.090 |
Why?
|
| Occipital Lobe | 3 | 1998 | 9 | 0.080 |
Why?
|
| Social Adjustment | 1 | 2009 | 27 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 370 | 0.080 |
Why?
|
| Biomarkers | 3 | 2019 | 581 | 0.080 |
Why?
|
| Evoked Potentials | 1 | 2008 | 14 | 0.080 |
Why?
|
| Task Performance and Analysis | 1 | 2008 | 49 | 0.080 |
Why?
|
| Depression | 2 | 2016 | 452 | 0.080 |
Why?
|
| United States | 2 | 2021 | 2155 | 0.070 |
Why?
|
| Photic Stimulation | 2 | 2005 | 38 | 0.070 |
Why?
|
| Self Report | 2 | 2021 | 223 | 0.070 |
Why?
|
| Amnesia | 2 | 1998 | 27 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2004 | 990 | 0.070 |
Why?
|
| Probability | 2 | 2021 | 91 | 0.070 |
Why?
|
| Leg | 1 | 2007 | 52 | 0.070 |
Why?
|
| Frontal Lobe | 2 | 2018 | 83 | 0.070 |
Why?
|
| Temporal Lobe | 2 | 2018 | 86 | 0.070 |
Why?
|
| Psychotropic Drugs | 1 | 2007 | 28 | 0.070 |
Why?
|
| Mobility Limitation | 1 | 2007 | 95 | 0.070 |
Why?
|
| Psychometrics | 2 | 2004 | 243 | 0.070 |
Why?
|
| Neurologic Examination | 1 | 2007 | 115 | 0.070 |
Why?
|
| Independent Living | 2 | 2020 | 308 | 0.070 |
Why?
|
| Comorbidity | 1 | 2007 | 497 | 0.060 |
Why?
|
| Atrophy | 1 | 2005 | 91 | 0.060 |
Why?
|
| Logic | 1 | 2004 | 3 | 0.060 |
Why?
|
| Catholicism | 1 | 2004 | 21 | 0.060 |
Why?
|
| Religion and Psychology | 1 | 2004 | 25 | 0.060 |
Why?
|
| Clergy | 1 | 2005 | 90 | 0.060 |
Why?
|
| Reference Values | 1 | 2004 | 201 | 0.060 |
Why?
|
| Speech Perception | 1 | 2004 | 55 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2004 | 103 | 0.050 |
Why?
|
| Paired-Associate Learning | 1 | 2001 | 4 | 0.050 |
Why?
|
| Spatial Processing | 1 | 2021 | 7 | 0.050 |
Why?
|
| Principal Component Analysis | 1 | 2021 | 26 | 0.050 |
Why?
|
| Oxygen | 2 | 2011 | 80 | 0.050 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2016 | 96 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2022 | 201 | 0.040 |
Why?
|
| Research Design | 1 | 2021 | 204 | 0.040 |
Why?
|
| Dissociative Disorders | 1 | 1998 | 3 | 0.040 |
Why?
|
| Community Health Planning | 1 | 2018 | 22 | 0.040 |
Why?
|
| Demography | 1 | 2018 | 75 | 0.040 |
Why?
|
| Mental Processes | 1 | 1998 | 20 | 0.040 |
Why?
|
| Social Isolation | 1 | 2018 | 25 | 0.040 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2017 | 5 | 0.040 |
Why?
|
| Amyloidosis | 1 | 2017 | 26 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 20 | 0.030 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2017 | 7 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 1998 | 214 | 0.030 |
Why?
|
| Epilepsy | 1 | 1997 | 65 | 0.030 |
Why?
|
| Genome | 1 | 2016 | 9 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 11 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2017 | 47 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 30 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 44 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 28 | 0.030 |
Why?
|
| Transcriptome | 1 | 2016 | 86 | 0.030 |
Why?
|
| Arterial Pressure | 1 | 2016 | 13 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 141 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 154 | 0.030 |
Why?
|
| Incidence | 1 | 2018 | 750 | 0.030 |
Why?
|
| Phenotype | 1 | 2016 | 306 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 121 | 0.030 |
Why?
|
| Sialic Acid Binding Ig-like Lectin 3 | 1 | 2015 | 14 | 0.030 |
Why?
|
| Neoplasms | 1 | 2018 | 236 | 0.030 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2016 | 114 | 0.030 |
Why?
|
| Alleles | 1 | 2015 | 209 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 204 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2014 | 69 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2014 | 38 | 0.030 |
Why?
|
| Glucose | 1 | 2014 | 62 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2014 | 54 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 90 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2015 | 254 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 1201 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2014 | 423 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2018 | 1748 | 0.030 |
Why?
|
| Sleep | 1 | 2016 | 337 | 0.030 |
Why?
|
| Stroke | 1 | 2016 | 272 | 0.030 |
Why?
|
| Child | 1 | 2017 | 1407 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2012 | 37 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 41 | 0.020 |
Why?
|
| Games, Experimental | 1 | 2011 | 9 | 0.020 |
Why?
|
| Animals | 1 | 2019 | 3824 | 0.020 |
Why?
|
| Nerve Net | 1 | 2011 | 46 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 2289 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 2043 | 0.020 |
Why?
|
| Word Association Tests | 2 | 1999 | 3 | 0.020 |
Why?
|
| Illinois | 1 | 2009 | 245 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 1998 | 275 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 1999 | 582 | 0.020 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2005 | 13 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2005 | 83 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2014 | 3530 | 0.010 |
Why?
|
| Chicago | 1 | 2007 | 902 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2005 | 328 | 0.010 |
Why?
|
| Personality Disorders | 1 | 2004 | 17 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 492 | 0.010 |
Why?
|
| Visual Cortex | 1 | 1998 | 7 | 0.010 |
Why?
|
| Visual Pathways | 1 | 1998 | 5 | 0.010 |
Why?
|
| Anomia | 1 | 1998 | 2 | 0.010 |
Why?
|
| Size Perception | 1 | 1998 | 2 | 0.010 |
Why?
|
| Orientation | 1 | 1998 | 6 | 0.010 |
Why?
|
| Concept Formation | 1 | 1998 | 10 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1998 | 96 | 0.010 |
Why?
|